NewDays Announces $7 Million In Seed Funding For Its Program To Treat Mild Cognitive Impairment

NewDays announced an oversubscribed $7 million seed funding from General Catalyst and Madrona and the expansion of its science-backed cognitive health treatment program to Texas, following a successful pilot phase in California, Washington, and Florida.

NewDays combines regular telehealth appointments with expert clinicians and AI-powered cognitive exercises delivered by its AI companion, Sunny, the announcement stated. Between appointments, engagement with Sunny includes clinician-assigned, long-form conversational exercises that bolster verbal fluency, improve memory, prevent social isolation, and build strategies for overcoming daily functional challenges, according to the announcement.

NewDays is based on evidence from more than 300 . . .